Evidence map›Paper›PMID 27343196›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2016

Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium.

Anantha Harijith, Srikanth Pendyala, David L Ebenezer, Alison W Ha, Panfeng Fu, Yue-Ting Wang, Ke Ma, Peter T Toth, Evgeny V Berdyshev, Prasad Kanteti and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Sphingolipids in mitochondria-from function to disease.Frontiers in cell and developmental biology · 2023
    Review
  8. Article
  9. [Research advances of the roles of sphingosine-1-phosphate in acute lung injury].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. S1P/S1PAntioxidants (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Hyperoxia-induced S1PCell biochemistry and biophysics · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anantha HarijithDepartment of Pediatrics, National Jewish Health, Denver, Colorado; Department of Pharmacology, National Jewish Health, Denver, Colorado; harijith@uic.edu.
Srikanth PendyalaDepartment of Pharmacology, National Jewish Health, Denver, Colorado;
David L EbenezerDepartment of Biochemistry & Molecular Genetics, National Jewish Health, Denver, Colorado;
Alison W HaDepartment of Pediatrics, National Jewish Health, Denver, Colorado;
Panfeng FuDepartment of Pharmacology, National Jewish Health, Denver, Colorado;
Yue-Ting WangDepartment of Medicinal Chemistry, National Jewish Health, Denver, Colorado;
Ke MaDepartment of Pathology, National Jewish Health, Denver, Colorado;
Peter T TothDepartment of Pathology, National Jewish Health, Denver, Colorado;
Evgeny V BerdyshevDepartment of Medicine, National Jewish Health, Denver, Colorado; and.
Prasad KantetiDepartment of Pharmacology, National Jewish Health, Denver, Colorado;
Viswanathan NatarajanDepartment of Pharmacology, National Jewish Health, Denver, Colorado; Department of Biochemistry & Molecular Genetics, National Jewish Health, Denver, Colorado; Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
University of Illinois Chicago · USUniversity of Colorado Denver · US

Funding

Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
NHLBI NIH HHS P01 HL098050
6 · The paper itself

Abstract

Hyperoxia-induced lung injury adversely affects ICU patients and neonates on ventilator assisted breathing. The underlying culprit appears to be reactive oxygen species (ROS)-induced lung damage. The major contributor of hyperoxia-induced ROS is activation of the multiprotein enzyme complex NADPH oxidase. Sphingosine-1-phosphate (S1P) signaling is known to be involved in hyperoxia-mediated ROS generation; however, the mechanism(s) of S1P-induced NADPH oxidase activation is unclear. Here, we investigated various steps in the S1P signaling pathway mediating ROS production in response to hyperoxia in lung endothelium. Of the two closely related sphingosine kinases (SphKs)1 and 2, which synthesize S1P from sphingosine, only Sphk1(-/-) mice conferred protection against hyperoxia-induced lung injury. S1P is metabolized predominantly by S1P lyase and partial deletion of Sgpl1 (Sgpl1(+/-)) in mice accentuated lung injury. Hyperoxia stimulated S1P accumulation in human lung microvascular endothelial cells (HLMVECs), and downregulation of S1P transporter spinster homolog 2 (Spns2) or S1P receptors S1P1&2, but not S1P3, using specific siRNA attenuated hyperoxia-induced p47(phox) translocation to cell periphery and ROS generation in HLMVECs. These results suggest a role for Spns2 and S1P1&2 in hyperoxia-mediated ROS generation. In addition, p47(phox) (phox:phagocyte oxidase) activation and ROS generation was also reduced by PF543, a specific SphK1 inhibitor in HLMVECs. Our data indicate a novel role for Spns2 and S1P1&2 in the activation of p47(phox) and production of ROS involved in hyperoxia-mediated lung injury in neonatal and adult mice.

Indexed as

Aldehyde-LyasesAnimalsAnion Transport ProteinsCells, CulturedEndothelial CellsEndothelium, VascularEnzyme ActivationFemaleHumansHyperoxiaLungLysophospholipidsMice, Inbred C57BLMice, KnockoutMicrovesselsNADPH OxidasesAldehyde-LyasesAnion Transport ProteinsLysophospholipidsNADPH Oxidasesneutrophil cytosolic factor 1Reactive Oxygen SpeciesSphingosinesphingosine 1-phosphatesphingosine 1-phosphate lyase (aldolase)Spns2 protein, humanNADPH oxidasep47phoxS1P receptorssphingosine-1-phosphatesphingosine kinase

Identifiers

PMID27343196
PMCPMC5142460
OpenAlexW2471950501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.